Andrew J. Elia1 article listing Andrew J. Elia in Nature Communications, indexed by Paperzzz from Crossref and OSF.Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial Nature Communications